Literature DB >> 15995506

Neck dissection followed by radiotherapy or chemoradiotherapy for small primary oropharynx carcinoma with cervical metastasis.

Ashok N Reddy1, David W Eisele, Arlene A Forastiere, Ding J Lee, William H Westra, Joseph A Califano.   

Abstract

OBJECTIVES: A cohort of patients with small primary (T1-T2) squamous cell carcinoma of the oropharynx and advanced cervical nodal metastasis were treated with initial neck dissection(s) followed by definitive radiation therapy with or without chemotherapy. Our rationale for this algorithm and our results are examined. STUDY
DESIGN: Retrospective chart review.
METHODS: Pathology records and medical records from 1996 to 2003 from the Johns Hopkins Hospital were examined for patients meeting the inclusion criteria.
RESULTS: Sixteen patients meeting the inclusion criteria were identified. Follow-up periods ranged from 6 to 75 months. Mean and median follow-up periods were 38 and 33 months, respectively. One (6.25%) patient developed a metastasis and was alive with disease at last follow-up. Fifteen (93.75%) patients were alive without evidence of disease at last follow-up. Overall survival was 100%. Disease free survival was 93.75%.
CONCLUSION: Initial neck dissection followed by primary radiation therapy to the primary site and neck with or without chemotherapy is an effective therapy for small primary oropharynx cancers with N2 or greater cervical metastases.

Entities:  

Mesh:

Year:  2005        PMID: 15995506     DOI: 10.1097/01.MLG.0000162643.91849.79

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Up-front neck dissection followed by concurrent chemoradiation in patients with regionally advanced head and neck cancer.

Authors:  Peter A Paximadis; Michael E Christensen; Greg Dyson; Dev P Kamdar; Ammar Sukari; Ho-Sheng Lin; George H Yoo; Harold E Kim
Journal:  Head Neck       Date:  2012-02-06       Impact factor: 3.147

2.  Neck dissection followed by definitive radiotherapy for small upper aerodigestive tract squamous cell carcinoma, with advanced neck disease: an alternative treatment strategy.

Authors:  Ashok M Shenoy; T Shiva Kumar; V Prashanth; Purushotham Chavan; Rajshekar Halkud; Linu Jacob; K Govind Babu; G Lokesh; Tanveer Pasha; Rekha V Kumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-01-06

Review 3.  Current trends in initial management of oropharyngeal cancer: the declining use of open surgery.

Authors:  Missak Haigentz; Carl E Silver; June Corry; Eric M Genden; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12       Impact factor: 2.503

4.  HPV-related oropharyngeal carcinoma with Overt Level II and/or III metastases at presentation: The risk of subclinical disease in ipsilateral levels IB, IV and V.

Authors:  Giuseppe Sanguineti; Sara Pai; Harold Agbahiwe; Francesco Ricchetti; William Westra; Maria Pia Sormani; Stefania Clemente; Joseph Califano
Journal:  Acta Oncol       Date:  2013-11-25       Impact factor: 4.089

Review 5.  Synchronous bilateral tonsil carcinoma: case presentation and review of the literature.

Authors:  M-N Theodoraki; J A Veit; T K Hoffmann; J Greve
Journal:  Infect Agent Cancer       Date:  2017-06-26       Impact factor: 2.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.